Amgen Inc.
AMGN
$289.33
$4.351.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.77B | 7.87B | 8.72B | 8.15B | 8.04B |
| Total Other Revenue | 408.00M | 276.00M | 370.00M | 352.00M | 347.00M |
| Total Revenue | 9.18B | 8.15B | 9.09B | 8.50B | 8.39B |
| Cost of Revenue | 2.67B | 2.61B | 712.00M | 3.31B | 2.58B |
| Gross Profit | 6.51B | 5.54B | 8.37B | 5.19B | 5.81B |
| SG&A Expenses | 1.69B | 1.69B | 1.88B | 1.63B | 1.79B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 77.00M | 30.00M | 65.00M | 64.00M | 11.00M |
| Total Operating Expenses | 6.18B | 5.81B | 4.38B | 6.45B | 5.82B |
| Operating Income | 3.00B | 2.34B | 4.71B | 2.05B | 2.57B |
| Income Before Tax | 1.57B | 1.97B | 782.00M | 3.10B | 794.00M |
| Income Tax Expenses | 136.00M | 243.00M | 155.00M | 271.00M | 48.00M |
| Earnings from Continuing Operations | 1.43B | 1.73B | 627.00M | 2.83B | 746.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.43B | 1.73B | 627.00M | 2.83B | 746.00M |
| EBIT | 3.00B | 2.34B | 4.71B | 2.05B | 2.57B |
| EBITDA | 4.34B | 3.73B | 5.99B | 3.45B | 3.97B |
| EPS Basic | 2.66 | 3.22 | 1.17 | 5.27 | 1.39 |
| Normalized Basic EPS | 1.55 | 1.93 | 5.00 | 1.62 | 1.39 |
| EPS Diluted | 2.65 | 3.20 | 1.16 | 5.22 | 1.38 |
| Normalized Diluted EPS | 1.54 | 1.92 | 4.95 | 1.60 | 1.38 |
| Average Basic Shares Outstanding | 538.00M | 538.00M | 537.00M | 537.00M | 537.00M |
| Average Diluted Shares Outstanding | 541.00M | 541.00M | 542.00M | 542.00M | 541.00M |
| Dividend Per Share | 2.38 | 2.38 | 2.25 | 2.25 | 2.25 |
| Payout Ratio | 89.39% | 73.93% | 192.19% | 42.76% | 162.06% |